Clinical Trial Update: NAL ER IPF Respiratory Function and Safety Study [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for NAL ER evaluating respiratory function and safety in idiopathic pulmonary fibrosis; recruiting is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• NAL ER

Snippet

Sponsor: Trevi Therapeutics | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: RECRUITING